122 related articles for article (PubMed ID: 7599696)
21. The pancreatic glucagon and C-peptide secretion during hyperinsulinemia in euglycemic glucose clamp with or without somatostatin infusion in normal man.
Wu MS; Ho LT
Horm Metab Res; 1987 Jun; 19(6):253-6. PubMed ID: 2887501
[TBL] [Abstract][Full Text] [Related]
22. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
Sakai T; Ohneda A; Nihei J; Kobayashi T
Tohoku J Exp Med; 1982 Dec; 138(4):427-40. PubMed ID: 6761899
[TBL] [Abstract][Full Text] [Related]
23. Deficient counterregulatory hormone responses during hypoglycemia in a patient with insulinoma.
Davis MR; Shamoon H
J Clin Endocrinol Metab; 1991 Apr; 72(4):788-92. PubMed ID: 2005202
[TBL] [Abstract][Full Text] [Related]
24. Failure to suppress C-peptide secretion by euglycaemic hyperinsulinaemia: a new diagnostic test for insulinoma?
Yki-Järvinen H; Pelkonen R; Koivisto VA
Clin Endocrinol (Oxf); 1985 Oct; 23(4):461-6. PubMed ID: 2998651
[TBL] [Abstract][Full Text] [Related]
25. Differentiation of insulin secretion patterns in insulinoma.
Saddig C; Goretzki PE; Starke AA
World J Surg; 2008 May; 32(5):918-29. PubMed ID: 18259806
[TBL] [Abstract][Full Text] [Related]
26. Insulin surrogates in insulinoma.
O'Brien T; O'Brien PC; Service FJ
J Clin Endocrinol Metab; 1993 Aug; 77(2):448-51. PubMed ID: 8345050
[TBL] [Abstract][Full Text] [Related]
27. Lack of suppression of insulin secretion by exercise in patients with insulinoma.
Järhult J; Ericsson M; Holst J; Ingemansson S
Clin Endocrinol (Oxf); 1981 Oct; 15(4):391-4. PubMed ID: 6274547
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis of insulinoma and the euglycemic hyperinsulinemic clamp technique.
Service FJ
Ann Intern Med; 1985 Mar; 102(3):417-8. PubMed ID: 2982309
[No Abstract] [Full Text] [Related]
29. Insulin and glucagon secretion are suppressed equally during both hyper- and euglycemia by moderate hyperinsulinemia in patients with diabetes mellitus.
Murayama Y; Kawai K; Watanabe Y; Yoshikawa H; Yamashita K
J Clin Endocrinol Metab; 1989 May; 68(5):925-31. PubMed ID: 2654170
[TBL] [Abstract][Full Text] [Related]
30. C-peptide during the prolonged fast in insulinoma.
Service FJ; O'Brien PC; McMahon MM; Kao PC
J Clin Endocrinol Metab; 1993 Mar; 76(3):655-9. PubMed ID: 8445021
[TBL] [Abstract][Full Text] [Related]
31. Experience with the Biostator for diagnosis and assisted surgery of 21 insulinomas.
Gin H; Catargi B; Rigalleau V; Rullier E; Roger P; Tabarin A
Eur J Endocrinol; 1998 Oct; 139(4):371-7. PubMed ID: 9820612
[TBL] [Abstract][Full Text] [Related]
32. Relapse of medically treated insulinoma following the development of thyrotoxicosis: an assessment of potential mechanisms.
Walker M; Trajano LR; Alberti KG; Kendall-Taylor P
Thyroid; 1994; 4(1):73-6. PubMed ID: 8054864
[TBL] [Abstract][Full Text] [Related]
33. Absence of clinically overt atherosclerotic vascular disease and adverse changes in cardiovascular risk factors in 70 patients with insulinoma.
Leonetti F; Iozzo P; Giaccari A; Sbraccia P; Buongiorno A; Tamburrano G; Andreani D
J Endocrinol Invest; 1993 Dec; 16(11):875-80. PubMed ID: 8144864
[TBL] [Abstract][Full Text] [Related]
34. C-peptide suppression test: effects of gender, age, and body mass index; implications for the diagnosis of insulinoma.
Service FJ; O'Brien PC; Kao PC; Young WF
J Clin Endocrinol Metab; 1992 Jan; 74(1):204-10. PubMed ID: 1727822
[TBL] [Abstract][Full Text] [Related]
35. Glucose transporter proteins in human insulinoma.
Boden G; Murer E; Mozzoli M
Ann Intern Med; 1994 Jul; 121(2):109-12. PubMed ID: 8017722
[TBL] [Abstract][Full Text] [Related]
36. Unresponsiveness of insulinoma cells to secretin: significance of the secretin test in patients with insulinoma.
Imamura M; Hattori Y; Nishida O; Honda T; Shimada Y; Miyahara T; Wagata T; Baba N; Tobe T
Pancreas; 1990 Jul; 5(4):467-73. PubMed ID: 2166285
[TBL] [Abstract][Full Text] [Related]
37. Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function.
Verdonk CA; Rizza RA; Nelson RL; Go VL; Gerich JE; Service FJ
J Clin Invest; 1980 May; 65(5):1119-25. PubMed ID: 6988457
[TBL] [Abstract][Full Text] [Related]
38. Effect of hyperlipacidemia on plasma C-peptide concentration during euglycemic hyperinsulinemic clamp.
Conget I; Gonzalez-Clemente JM; Casals E; Casamitjana R; Gomis R; Malaisse WJ
Diabetes Res; 1993; 22(1):41-8. PubMed ID: 8200184
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of fasting hypoglycemia and concomitant insulin resistance in insulinoma patients.
Del Prato S; Riccio A; Vigili de Kreutzenberg S; Dorella M; Avogaro A; Marescotti MC; Tiengo A
Metabolism; 1993 Jan; 42(1):24-9. PubMed ID: 8446044
[TBL] [Abstract][Full Text] [Related]
40. Hypertriglyceridemia and hyperinsulinemia are potent inducers of endothelin-1 release in humans.
Piatti PM; Monti LD; Conti M; Baruffaldi L; Galli L; Phan CV; Guazzini B; Pontiroli AE; Pozza G
Diabetes; 1996 Mar; 45(3):316-21. PubMed ID: 8593936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
